PubMed Health⌕ Search

Biomedical subjects

A F Fransway

Publications and source records attributed to A F Fransway.

24 records · Page 2Linked to original sources

Epicutaneous patch testing: current trends and controversial topics.

In the 20th century, epicutaneous patch testing has played an integral and central role in the assessment of allergic contact dermatitis and therefore in general dermatologic practice. After recent verification of the safety and accuracy of patch testing by the Food and Drug Administration, domestic distribution of testing materials has resumed for the first time in 5 years. Because of the importance of this procedure, it is timely to review current standards of epicutaneous patch testing with emphasis on proper use and interpretation, clinical applications, trends in allergic contact dermatitis, and selected controversial issues.

Adult↗

Patch testing in prurigo nodularis.

32 patients with prurigo nodularis evaluated at the Mayo Clinic from 1975 to 1987 have been patch tested for sensitivity to appropriate allergen series; 25 of these had relevant positive reactions and subsequent follow-up to 5 to 14 years was available for 11. 6 patients had persistent disease and 5 had resolution or marked improvement. 3 of these latter patients noted a strong positive correlation between improvement and avoidance of contact allergens. Screening for contact sensitivity may be helpful in the management of this refractory dermatosis, particularly if there is a coexistent dermatitis.

Adrenal Cortex Hormones↗

Sensitivity to Kathon CG: findings in 365 consecutive patients.

In the period from 1983 through 1986, 365 consecutive patients suspected as having allergic contact dermatitis were tested for reaction to Kathon CG. This test was positive in 20 of these patients: irritant responses in 7 and allergic sensitivity in 13. Provocative use testing was positive in 1 of the 3 allergic patients tested. The characteristics of this group of patients include having a mean age older than that of the general population or of our population of dermatologic patients, having histories of long-standing dermatitis, and reporting exposure to various leave-on formulations. Our rate of positive tests, 3.6%, is similar to that reported by other investigators, although sensitivity testing results differ from center to center. It is recommended that, in certain clinical situations, caution be exercised in the unsupervised use of leave-on products containing Kathon CG.

Adult↗

Chronic dermatitis evolving to mycosis fungoides: report of four cases and review of the literature.

In four patients with long-standing chronic dermatitis, evolution into cutaneous T-cell lymphoma was observed. Two patients were men and two were women; they were aged forty-nine to sixty-five years at first presentation. Duration of dermatitis at admission was from two months to fifteen years, with the clinical and histologic diagnosis documented on initial examination. After another five to nine years, clinically and histologically verified mycosis fungoides occurred. In two patients, contact factors were verified as causative by results of patch testing; sensitivities documented included nickel, potassium dichromate, and formaldehyde. In a third patient, contact factors were implicated as causes, but patch testing was not performed. We propose that certain instances of cutaneous T-cell lymphoma may be caused by chronic antigenic immunostimulation with resultant malignant lymphocyte clonality.

Aged↗

3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.

The efficacy of a 3 percent topical minoxidil solution (2,4-diamino-6-piperidinopyrimidine-3-oxide) in a propylene glycol-water-ethanol base applied twice daily for one year to half the scalp was evaluated in patients with severe chronic alopecia areata. A randomized, double-blind, bilateral comparison-controlled study design was used. Of the twenty-one patients, thirteen were women and eight were men; their ages ranged from nineteen to fifty-five years. All the patients had alopecia totalis or alopecia universalis, except for two who had lost two-thirds of their scalp hair. The mean disease duration was 11.5 years (range, one to forty years). Transient regrowth of sparse vellus hair occurred in twelve patients, bilaterally in eight, but it was not significant in any. No cosmetically acceptable results were achieved. No significant side effects were noted, except for a moderately severe bilateral dermatitis in one patient. The results indicate that 3 percent topical minoxidil solution is ineffective as treatment for severe chronic alopecia areata.

Administration, Topical↗